Drug Shortage Report for THALOMID

Last updated on 2024-06-13 History
Report ID 228619
Drug Identification Number 02355191
Brand name THALOMID
Common or Proper name THALIDOMIDE
Company Name BRISTOL-MYERS SQUIBB CANADA
Market Status MARKETED
Active Ingredient(s) THALIDOMIDE
Strength(s) 50MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 2X14
ATC code L04AX
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-05-24
Actual start date
Estimated end date 2024-06-24
Actual end date 2024-06-12
Shortage status Resolved
Updated date 2024-06-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
ST-LAURENT, QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2024-06-13 English Compare
v7 2024-06-12 French Compare
v6 2024-06-12 English Compare
v5 2024-05-25 French Compare
v4 2024-05-24 French Compare
v3 2024-05-24 English Compare
v2 2024-05-24 French Compare
v1 2024-05-24 English Compare

Showing 1 to 8 of 8